SINGAPORE--(BUSINESS WIRE)--Sengenics, the Functional Proteomics Company, today announced the launch of ImmuSAFE™ COVID+, a multi-antigen, multi-domain, fully quantitative serology test. ImmuSAFE™ ...

High-throughput screening is a valuable tool in drug discovery, enabling the identification of small molecule modulators of biochemical activities and interactions. Traditional methodologies rely on ...

Ottawa, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The global biochip market size was valued at USD 12.75 billion in 2024 and is predicted to hit around USD 42.15 billion by 2034, rising at a 12.7% CAGR, a ...

High-throughput screening assays can identify small molecule modulators of biochemical activities and interactions from large libraries of active compounds in drug discovery studies. However, ...

Microarray density continues to climb. In the past year, several companies have compressed the entire protein-coding portion of the human genome onto a single chip – that's some 30,000 to 40,000 ...

Digital microfluidics and biochip technologies represent a rapidly evolving interdisciplinary field that integrates principles of physics, chemistry and engineering to manipulate discrete droplets ...

TORONTO, May 16, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge ...